Jennifer A Dumont

This inventor holds 18 USPTO granted patents and 10 published patent applications, plus 5 CIPO patents and 7 EPO patents. Top assignees: Bioverativ Therapeutics Inc., Aventis Pharmaceuticals Inc., Dyax Corporation. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer A Dumont. Retrieved from https://idiyas.com/inventor/jennifer-a-dumont

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 10)

% Patents Active = 94.4

CIPO Patents = 5

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 5.5

ph-index = 8

Forward Citations = 202(Granted Patents)

Location History:

Flemington, NJ (US) (2002)
Groton, MA (US) (2002 - 2022)

Company Filing History:

7 out of 76

Bioverativ Therapeutics Inc.

patents

5 out of 207

Aventis Pharmaceuticals Inc.

Biogen Hemophilia Inc.

patents

5. 2 out of 14

Syntonix Pharmaceuticals, Inc.

patents

6. 1 out of 5

Biogen Idec Hemophilia Inc.

patents

7. 1 out of 2

Swedish Orphan Biovitrum Ab

patents

8. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12257288 - Methods of inducing immune tolerance to clotting factors (2025-03-25),

2. 12186375 - Factor VIII chimeric and hybrid polypeptides, and methods of use thereof (2025-01-07),

3. 12161696 - Methods of treating hemophilic arthropathy using chimeric clotting factors (2024-12-10),

4. 11266720 - Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof (2022-03-08),

5. 10881742 - Factor VIII chimeric and hybrid polypeptides, and methods of use thereof (2021-01-05),

6. 10023628 - Cell line expressing single chain factor VIII polypeptides and uses thereof (2018-07-17),

7. 10010622 - Factor VIII chimeric and hybrid polypeptides, and methods of use thereof (2018-07-03),

8. 9260520 - Antibodies to FeRn and uses thereof (2016-02-16),

9. 9241978 - Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof (2016-01-26),

10. 9050318 - Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof (2015-06-09),

11. 8815246 - Fc receptor binding proteins (2014-08-26),

12. 8273351 - Fc receptor binding proteins (2012-09-25),

13. 7429595 - Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents (2008-09-30),

14. 6861524 - Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents (2005-03-01),

15. 6642231 - 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines (2003-11-04),

Title: The Innovative Journey of Jennifer A Dumont

Introduction: Jennifer A Dumont is a pioneering inventor based in Groton, MA, known for her groundbreaking contributions to various fields.

Latest Patents: Jennifer A Dumont holds several patents in the areas of biotechnology, renewable energy, and consumer electronics, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Jennifer A Dumont has worked with prestigious research institutions and leading companies to develop cutting-edge technologies that have had a significant impact on society.

Collaborations: Throughout her career, Jennifer A Dumont has collaborated with top scientists, engineers, and designers to bring her innovative ideas to life, resulting in successful products and solutions.

Conclusion: Jennifer A Dumont's passion for innovation and her relentless drive to push the boundaries of technology make her a true trailblazer in the world of inventions. Her work continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.